Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Synopsys (SNPS) PT Raised to $370 at Needham & Company
December 2, 2021 6:43 AM ESTNeedham & Company analyst Charles Shi raised the price target on Synopsys (NASDAQ: SNPS) to $370.00 (from $360.00) while maintaining a Buy rating.
The analyst commented, "Synopsys reported in-line results for F4Q21 (Oct) and guided F1Q22 (Jan) and FY22 meaningfully higher than respective consensus... More
Synopsys (SNPS) Tops Q4 EPS by 4c; Guides Above
December 1, 2021 4:13 PM ESTSynopsys (NASDAQ: SNPS) reported Q4 EPS of $1.82, $0.04 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.14 billion.
GUIDANCE:
Synopsys sees Q1 2022 EPS of $2.35-$2.40, versus the consensus of $1.76. Synopsys sees Q1... More
